![Georges Rawadi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Georges Rawadi
Former positions of Georges Rawadi
Companies | Position | Start | End |
---|---|---|---|
CELYAD ONCOLOGY SA | Director/Board Member | 2023-04-26 | 2023-11-30 |
Chief Executive Officer | 2023-04-26 | 2023-11-30 | |
YSOPIA Biosciences SA
![]() YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Director/Board Member | 2018-02-28 | 2021-08-31 |
Chief Executive Officer | 2018-02-28 | 2021-08-31 | |
CELYAD ONCOLOGY SA | Corporate Officer/Principal | 2014-05-31 | 2018-03-22 |
CELLECTIS S.A. | Corporate Officer/Principal | - | - |
Training of Georges Rawadi
ESSEC Business School | Graduate Degree |
Statistics
International
France | 5 |
Belgium | 2 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CELYAD ONCOLOGY SA | Health Technology |
CELLECTIS S.A. | Health Technology |
Private companies | 2 |
---|---|
Université Pierre et Marie Curie | Consumer Services |
YSOPIA Biosciences SA
![]() YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
- Stock Market
- Insiders
- Georges Rawadi
- Experience